This Solicitation opportunity from Department Of Defense was posted on May 31, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
FLUTICASONE PROPION
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The contract outlines the procurement of Fluticasone Propionate inhalation aerosol, specifically a 220 mcg inhaler with a 12gm aerosol canister delivering 120 metered doses per unit. The product must be free of chlorofluorocarbons, stored at room temperature, and possess a shelf life of 18 months, with a minimum of 15 months remaining from manufacture to delivery. Labeling and marking requirements adhere to Medical Marking Standard No. 1A, including essential details such as the National Stock Number (NSN), manufacturer and CAGE code, manufacture and expiration dates, and contract or lot number. Packaging must comply with commercial standards suitable to prevent damage, utilize sealed containers, and meet federal packaging criteria outlined by the Defense Logistics Agency (DLA), with special instructions for hazardous materials packaging if applicable. The contract specifies delivery of five individual units for a total quantity of five inhalers, with delivery to be made within five days FOB destination, with inspection and acceptance also at the destination point. The procurement is governed by technical and quality requirements listed on the DLA Master List, and includes relevant defense information protections and FDA regulatory constraints. The shipment is designated for delivery to the USS George Washington (FPO AP 96607) with additional coordination instructions for transportation and packaging compliance. The solicitation was issued by the Department of Defense’s Medical Supply Chain Pharmacy and responses are due by June 8, 2026. The contract ensures strict control over material packaging, shelf life, marking, and delivery conditions to meet the stringent quality and logistical standards required for military medical supplies.
General Info
Agency
NAICS
Place of Performance
UNIT 100148 BOX 1, FPO, AP, 96607, USSet-Aside
Timeline
Submission Closed
Organization & Contact Information
Full Description
FLUTICASONE PROPIONATE INHALATION AEROSOL
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
220 MCG FLUTICASONE INHALER, 12GM AEROSOL
W/CANISTER 120 METERED DOSES, U/I 1 EA.
.
DOES NOT CONTAIN CHLOROFLUOROCARBONS
STORE AT ROOM TEMPERATURE
SHALL HAVE A SHELF LIFE OF 18 MONTHS.
NOT LESS THAN 15 MONTHS SHALL HAVE ELAPSED FROM
DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE
GOVERNMENT.
.
LABELING AND MARKING MUST IN ACCORDANCE WITH
MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013
.
LABELS SHALL INCLUDE:
NSN
MANUFACTURER AND CAGE
DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE
CONTRACT NUMBER/LOT NUMBER
.
.
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
SPE2DP-26-T-3588
SECTION B
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS013: Shelf-life requirement RS001 for a TYPE I (CODE K) item with a shelf life of 18 months (non-extendable) applies to this item.
GLAXOSMITHKLINE, LLC 667E9 P/N NDC66993-0080-96
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016956120 0001 EA 5.000
NSN/MATERIAL:6505015326922
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA-QUP:001
IF MATERIAL IS CONSIDERED HAZARDOUS IAW FED-STD-313,
PACKAGE IN ACCORDANCE WITH TQ REQUIREMENT IP025.
IF THE MATERIAL IS NOT CONSIDERED HAZARDOUS, IN ACCORDANCE WITH
FED-STD-313, THE MATERIAL SHALL BE COMMERCIALLY PACKAGED IN ACCORDANCE
WITH ASTM D3951.
All DLA Master List of Technical and Quality Requirements take precedence over ASTM D3951. Mark and label all packaging and packing in accordance with MIL-STD-129. The Unit of Issue (U/I) and Quantity per Unit Pack (QUP) will be as specified in the contract/purchase order. PALLETIZATION SHALL BE IN ACCORDANCE WITH RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
PARCEL POST ADDRESS:
R21412
SPE2DP-26-T-3588
SECTION B
PR: 7016956120 PRLI: 0001 CONT’D
USS GEORGE WASHINGTON CVN 73
UNIT 100148 BOX 1
FPO AP 96607
US
VESSEL SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
FREIGHT SHIPPING ADDRESS:
R21412
USS GEORGE WASHINGTON CVN 73
DLA VENDORS: USE VSM FOR
US
RDD 777 SHIPMENT. TRANSPORTATION SEE DLAD PROC NOTE C19. FIRST DESTINATION TRANSPORTATION SEE DLAD PROC
NOTE C20 AND CONTRACT
M/F: (TCN) R214125213P138
RDD: 777
PROJ: EK5 TP 1
SUPP ADD: SIG: A
FOR GOVERNMENT USE ONLY: (IPD) 02
DIC: A41 DIST: 9B ADV: 2A FC: L7
Need Ship Date:00/00/0000 Original Required Delivery Date:08/21/2025
SPE2DP-26-T-3588 NSN/Part Number: 6505-01-532-6922 Quantity: 5 EA Purchase Request: 7016956120QTY: 5 Delivery: 5 days ADO
